Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Link

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Blood|December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemiaZhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Clonal Hematopoiesis and Risk of Incident Lung CancerRuiyi Tian, Brian Wiley, Jie Liu, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Blood|December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemiaZhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Clonal Hematopoiesis and Risk of Incident Lung CancerRuiyi Tian, Brian Wiley, Jie Liu, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pageof 17